To investigate the functional heterogeneity of mouse mast cells, we extracted and purified cutaneous and peritoneal mast cells from 10-to 18-week-old BALB/c mice and compared their responses to secretagogues. Cutaneous mast cells (CMC) were extracted from mouse ears after digestion with hyaluronidase and collagenase in MEM containing 25% fetal calf serum and purified on a discontinuous Percoll gradient. The histamine content of cells obtained from the 30/ 40% interface was 1.0 ± 0.1 pg/ cell (mean± SE), with a mastcell purity of 68.6 ± 4.4% and a viability of> 93%. Peritoneal mast cells (PM C) were obtained by lavage with modified Tyrode's buffer followed by purification on 22.5% and 3-9% metrizamide gradients. The histamine content of cells was 12.2 ± 0.8 pg/cell, with a mast-cell purity of 95 .9 ± 0.6% and a viability of> 95%. Histamine release induced by
To investigate the functional heterogeneity of mouse mast cells, we extracted and purified cutaneous and peritoneal mast cells from 10-to 18-week-old BALB/c mice and compared their responses to secretagogues. Cutaneous mast cells (CMC) were extracted from mouse ears after digestion with hyaluronidase and collagenase in MEM containing 25% fetal calf serum and purified on a discontinuous Percoll gradient. The histamine content of cells obtained from the 30/ 40% interface was 1.0 ± 0.1 pg/ cell (mean± SE), with a mastcell purity of 68.6 ± 4.4% and a viability of> 93%. Peritoneal mast cells (PM C) were obtained by lavage with modified Tyrode's buffer followed by purification on 22.5% and 3-9% metrizamide gradients. The histamine content of cells was 12.2 ± 0.8 pg/cell, with a mast-cell purity of 95 .9 ± 0.6% and a viability of> 95%. Histamine release induced by A23187 from CMC peaked at 3.0 j.lM A23187 (19.1 ± 4.2%), at 3.0min (22.3±2.3%), and at 30oC (17.6 "± 2.6%). In contrast, histamine release from PMC peaked at 8.0 j.lM of A23187 (49.4 ± 12.1 %) and at 15.0 min (48.5 ± M ast cells are well know~ as c:itical partic~pants ~n a variety of important b10log1c processes mcludmg inflammatory reactions, cytotoxicity, angiogenesis, immunoregulation, and fibrosis [1] . BALB/c mice are a commonly used animal model for the study of cutaneous inflammation; however, their cutaneous mast cells have not been well characterized. This study was designed to extract, purify, and functionally characterize cutaneous mast. cells ( CMC) from BALB j c mice. In view of the known heterogene1~ of mucosal and connective tissue mast cells (2) (3) (4) (5) (6) (7) (8) (9) (10) , we exammed whether such heterogeneity exists in CMC and pe~itoneal mast cells (PM C) of BALB/c mice, both of wh1ch are con~1dered to be .connective tissue mast cells [11] . Therefore, the functlonal properties of Manuscript received November 7, 1989 ; accepted for publication March 16, 1990 Animals Female BALB/c mice, 10-to 18-week-old, were used (Taconic Laboratories, Germantown, NY).
Purification ofCMC CMC were dispersed from mouse ears by a modification of previously described enzymatic techniques [8, 12] . Mice were sacrificed by cervical dislocation; the ears were removed and immediately placed in MEM at room temperature. The ears were then pulled apart into two leaves, cut into fragments of approximately 1.0 mm with scissors, and washed with MEM containing 25% FCS (MEM/FCS). They were incubated for 60 min at 37" C in the same buffer (1 g tissue/30 ml buffer) containing collagenase, 1.5 mg/ml, and hyaluronidase, 0.5 mg/ml. The tissue was pressed against the sides of the culture tube every 15 min thereby facilitating digestion. Cells dispersed by this procedure were separated from tissue by filtration through Nytex Swiss nylon gauze (20 ,urn) (Tetko Inc., Lancaster, NY), washed twice in MEM/FCS, and sedimented by centrifugation at 500 X g for 5 min at room temperature. Undigested tissue was subjected to a second identical digestion procedure, and cells obtained from each digestion were pooled.
Percoll density medium was rendered isotonic by the addition of 10% final volume of 10 times concentrated HEPES-BSS containing deoxyribonuclease, 0.1 mgjml. Discontinuous density gradients were prepared in 15 ml conical centrifuge tubes (Fisher) by sequential layering of 2-ml samples of each of 60%, 50%, 40%, 30%, and 20% isotonic Percoll previously prepared by dilution with 5% MEM/FCS. Samples of 2 ml of freshly dispersed skin cells in 5% MEM/FCS containing 15 to 20 X 10 6 nucleated cells were layered on the gradients, which were then centrifuged at 500 X g for 10 min at room temperature. Cells were harvested at the interfaces between Percoll density layers of aspiration with a 1.0-ml pasteur pipette (Fisher), and the corresponding fractions from each gradient were pooled, diluted with four volumes of 25% MEM/FCS, and centrifuged at 500 X g for 5 min at room temperature. The recovered cells were washed in 25% MEM/FCS and suspended for quantitation and assessment of viability. In pilot studies (Table I) , the highest mast-cell purity was observed at the 30/40% interface; therefore, cells from this interface were used in all the functional experiments. Prior to activation, the cells were washed once with 25% MEM/FCS and resuspended in HEPES-BSS with 5% FCS. In experiments to evaluate the requirement for calcium, the latter buffer was replaced by HEPES-BSS lacking calcium and containing 1.0 mM EDTA. In experiments in which calcium reconstitution was performed, calcium was added to HEPES-BSS lacking calcium, and the reconstituted buffer was then used for washing and suspension of the cells.
Purification of PMC The animals were sacrificed by cervical dislocation. Six ml ofTyrode's buffer lacking calcium and magnesium containing 0.1% gelatin and 0.005% heparin were injected into the peritoneal cavities. The peritoneal lavage was collected in polypropylene tubes and centrifuged at 200 X g for 10 min at room temperature. The cell pellet was resuspended in TGD= and filtered through Nytex Swiss nylon gauze (20 ,um) . Two-ml suspensions of cells (5-1 0 mice/2 ml) were layered on 22.5% (w /v) metrizamide in TGD= and centrifuged at 500 X g for 15 min at room temperature. After washing twice in TGD=, the cells were resuspended in 5-6 ml TGD= and layered on 30 ml3-9% (w/v) continuous metrizamide gradients in TGD= and were centrifuged at 35 X g for 12 min at room temperature. The recovered cells were washed twice in TGD= and were suspended for quantitation and assessment of viability [13] . Prior to activation, the cells were washed once with and resuspended in TGD with 0.5% BSA. In experiments to study the requirement for calcium, TGD= containing 1.0 mM EDTA was used in these latter two steps.
Mast-Cell Quantitation and Viability Determination Mastcell numbers were determined under light microscopy after staining with 0.01 o/o toludine blue in ethyl alcohol. The purity of mast cells was calculated by dividing the number of mast cells by the total nucleated cells in each experiment. The viability was assessed by trypan blue exclusion.
Activation ofCMC and PMC Dose-response and kinetic studies with various secretagogues were carried out at 3 7 o C in duplicate. All cells and buff~rs were premcubated for 5 min at 37"C prior to use. In studies with CMC, HEPES-BSS containing 5% FCS was used. Three X 10 4 CMC in 450 ,ul was added to each tube, followed by the addition of buffer and dilutions of the secretagogue to give a final volume of 500 ,ul. In studies with PMC, TGD buffer with 0.5% BSA was used. Two hundred and twenty five microliters of PMC (6.7 X 10 4 cells/ml) was added to each tube, followed by the addition of buffer and dilutions of the secretagogue to yield a final volume of 450 ,ul. Based on the results of kinetic studies, in dose-response experiments, the CMC and PMC were exposed to the secretagogues for 3 min and 10 min. respectively. Reactions were terminated by the addition of 200 ,ul of ice-cold buffer, and the immersion of th~ tubes in an ice-water bath. After centrifugation at 200 X g for 5 mm at room temperature, supernatant fractions were separated; the cell pellets were suspended in ice-cold buffer in a volume equal to that of the original reaction mixture, and were disrupted by sonication.
Histamine Assay Histamine levels in the supernatant fractions and cell pellets were determined using a double-isotope radioenzyme assay described previously [14, 15] . The results were expressed as percent net histamine release, defined as percent stimulated release (histamine in supernatant/histamine in both supernata nt and pellet) minus percent background release. Each value represents the mean± SE.
RESULTS
Purification and Characterization of CMC and PMC As shown in Table II , CMC and PMC of a purity of 68.6 ± 4.4% and 95.9 ± 0.6%, respectively, were obtained. The histamine content of PMC was approximately 12 times higher than that of CMC (12.2 ± 0.8 pgjcell versus 1.0 ± 0.1 pg/cell), whereas the yield of CMCwas25timeshigherthanthatofPMC(1 X 10 6 CMC/ mouse versus 4 X 10 4 PMC/mouse). .... 
Response ofCMC and PMC to Calcium Ionophore (A23187)
Dose-Respor1se Analysis: For CMC, a maximum net histamine rele~se of 19.1 ± 4.2% was ob.served at 3.0 ,uM A23187 (Fig 1A) .
H1stamme release by PMC (F1g 1B) continued to increase in a dosedependent fashion over the concentration range tested (0. 4-8.0 ,uM), with a net release of 49.4 ± 12.1% noted at 8.0 ,uM A23187.
Time-Course Analysis:
To investigate the time course of histamine release from CMC and PMC in response to A23187, parallel experiments were performed by incubating CMC with 3.0 ,uM A23187
and PMC with 4.0 ,uM A23187. CMC had a maximum net histamine release of22.3 ± 2.3% at 3.0 min (Fig. 2A) . The time course of histamine release from PMC was slower, reaching a maximum net release of 48.5 ± 12.2% at the longest incubation time tested (15 min).
Temperature Dependence: For CMC, the maximum net histamine release of 17.6 ± 2.6% occurred in 30oC (Fig 3A) . Histamine release from PMC was of the same magnitude over the temperature range tested from 22 to 45°C (Fig 3B) . ment for extracellular calcium was corroborated in experiments in which the buffer (HEPES-BSS lacking in calcium) was reconstituted with increasing concentrations of calcium (0, 1, 2, 3, 4, and 5 mM). There was a calcium-dose-dependent increase in the release of histamine from CMC, reaching a plateau of net histamine release of 21.0 ± 1.0% at 2.0 mM calcium (Fig 4 ) . Similarly, the presence of EDT A suppressed the net release of histamine induced by 4.0 J.lM A23187 from PMC from 28.8 ± 1.3% to 4.0 ± 2.8% (n = 3), a suppression of 86% (data not shown) .
Requ irement for Calcium:

Effect of Purification Methods on Histamine Release
In the above experiments, CMC were exposed to hyaluronidase and collagenase during extraction, whereas PMC were exposed to heparin.
To evaluate the effect of these different reagents that of necessity were used in the extraction of CMC and PMC, CMC were incubated w ith buffer containing 0.005% heparin during the first hour of enzymatic digestion; collagenase (1.5 mg/ml) and hyaluronidase (0.5 mg/ml) were added to the buffer used for peritoneal lavage of PMC. Stimulation of these CMC and PMC for 10 min with A23187 (3.0 J.lM for CMC, 4.0 J.lM for PMC) resulted in hista. mine releases that were of the same magnitude as those observed when the cells were extracted and purified in the regular manner (data now shown), suggesting that the differences observed were inherent properties of CMC and PMC rather than secondary to exposures to different reagents. (Fig SA) . In contrast, net histamine release induced by this secretagogue from PMC continued to increase at all the concentrations examined, with a net maximal release of 31.9 ± 2.6% at compound 48/80 of 10.0 ,ugjml, the highest concentration tested (Fig. 5B) .
Time-Course Analysis:
The time course of histamine release induced by compound 48/80 was performed with 2.0 ,ugjml for CMC and 1.0 ,ugjml for PMC. Maximal release was observed at THE JOURNAL OF lNVESTlGATlVE DERMATOLOG\ 5 min for <:;Me,. with a net re lease of 16.3 ± 7.0% (Fig ?A) . T~ release of 111Stamme from PMC reached peak levels at 1 mm, wit~ similar degree of release noted at all the time points tested ovel' 10-min interval (Fig 6B) .
Response of CMC and PMC to Substance P (SP) Dose-Resporzse Analysis: SP is a neurogenic peptide known to i duce degranulation of human cutaneous and rat peritonea l mas t ce~ [16, 17] . Maximal histamine release at 5.0 ,uM SP was noted for bo CMC and PMC, with net release of 18.8 ± 6.6% and 12.6 ± 3. 7 1Jt
respectively (Fig 7 A,B) . .... 
Time-Course A11alysis:
The time-course analys is of histamine release, using a 5.0 ,uM SP, showed different responses between CMC and PMC. Maximal net release of 18.2 ± 3.2% was noted at 3.0 min for CMC (Fig. 8A ) , and maximal release of 11.4 ± 2.0% at 30.0 min for PMC (Fig 8B) . Requireme11t for Calcium: To evaluate the requirement for extracellular calcium in histamine release induced by SP, experiments were performed in the presence of 1.0 mM of EDT A. As shown in Table  IV , EDT A suppressed the release from CMC and PMC by 93% and 41 o/o, respectively, indicating that although there was an absolute requirement for calcium in histamine release induced by SP from CMC, release from PMC was only partially calcium dependent.
MAST-CELL HETEROGENEITY 183
Viability of CMC and PMC in the Presence of Secretagogues To evaluate if histamine release in the presence of secretagogues was due to alteration in mast-cell viability, the latter was examined. Identical incubation times were used as those in the doseresponse studies, and the highest concentration of the respective secretagogue was utilized. The viabilities of CMC following a 3-min incubation at 37 •c with secretagogues were, for A23187 ( 96.9 ± 0.6% . The above viabilities were in the same magnitude as those observed in the presence of respective buffers, which were > 90%.
DISCUSSION
We report purification of functional CMC and PMC from BALE/ c mice to a purity of 68.6 ± 4.4% and 95.9 ± 0.6%, respectively .
CMC were purified using a modification of techniques previously used to extract C MC from rats and humans [2, 8) . In order to minimize the leakage of histamine from CMC during extraction, buffers containing 25% FCS were used. To minimize the background histamine release during subsequent procedures, 5% FCS was used in the buffers; this res ulted in a background release of 11 .0 ± 1.0%
while rendering the cells responsive to stimulation by secretagogues. The meth od used to purify PMC was a modification of the method used previously by us to purify rat serosal mast cells [18) . To minimize the background release, it was necessary to suspend the cells to TGD containing 0.5% BSA; this resulted in a background histamine re lease of 5.2 ± 0.8%, while still rendering the cells responsive to stimulation by secretagogues. Mouse ears were used as the source of cutaneous mast cells because in previous studies, a large number of dermal mast cells were observed histologically in ears, and they were the major source of elevated serum histamine in phototoxic responses and in allergic contact hypersensitivity responses [19, 20) . Techn~ca lly, the tissue !s convenient to use because the ear has relatively httle hair and adipose tiss ue, and the cartilage is easily removed.
Calcium ionophore A23187 and compound 48/80 were sel.ected as secretagogues in this study because they ~re commonly usedm the study of mast-cell function. In humans, Intradermal mJeCt!On of compound 48/80 has been shown to induce a wheal and flare response (21} . Substance P, a neurop~ptide, was al.so chosen ? ecause it has been reported to be present 11~ human skm,. to parnctpate 111 cutaneo us inflammation, and to mduce histamme release from human cutaneous mast cells [22) . N europeptides, including SP, have been postulated to play a role in the pathogenesis of cutaneous lesions of atopic dermatitis [23) .
. Studies on secretory response of CMC mduced by A23187 shows that C MC had a peak histamine release at 3.0 11M A23187 (Fig.   1A) , at 3.0 min (Fig 2A ) , and at 3o •c {Fig. ~A). The~e responses were very similar to the results reported previOusly usm.g humanskin mast cells [8, 12] . As compared to CMC, net his.taml1le rel~ase from PMC continued to increase even at 8.0 11M A23187, the htghest concentration tes ted, and maximal histamine release was observed at 15 min (Fi gs. 1B, and 2B). PMC ~esponded well throughout the entire temperature range tes ted (Fi g 3B).
Of necessity, different reagents w ere used during the extraction of CM C and PMC, namely, hyaluronidase and collagenase were used for the former and heparin was used for the latter. To investigate if the different responses of CMC and PMC ~ere due to ~he different extrac tion procedures used , CMC were mcubated wtth heparin , and PMC were incubated with hyaluronidase and collagenase during their respective purification steps. The fact th. at cells so treated responded in manners similar to those extracted usmg the regular methods suggests that the different responses observed be-THE JO URNAL OF INVESTI GATIVE DERMATOLOG\\ tween CMC and PMC were due to heteroge neity of these eel[~ rather than to the extraction and purification procedures used.
Similar functional heterogeneity of CMC and PMC in the dose response, time-co urse, and calcium-requirement experiments w~ also observed using compound 48(80 and SP as secretagogues. Fo~ example, although maximal net histamme release was noted wit~ 5.0 ,uM SP for both CMC and PMC, peak release was achieveq WJthm 3.0 mm for the former and at 30.0 min for the latter. Th ere fore, taken to gether , the results of this study demonstrate for th~ first time that in BALB(c mice, heterogeneity exists between CM~ and PMC, both of whtch are constdered to be conn ecttve-tissu~ mast cells. These data support the concept that mast-cell heteroge\ neity ex1sts widely, not only between connective tissue m ast cell\ and mucosal mas t cells [12, 16] , but also among the same type 0~ mast cells in different tissues or different locations [2, 8] . Lowman e~ a\ [22) have extended the concept of mast-cell hetero ge neity to "-spectrum of mas t cells, each one specialized to perform individua( ~unctions within a particular tiss ue microenvironment. This theory ts supported by their different ultrastructures [24, 25) , different con •. tent of vasoactive amines and proteins [6, 26] , different numbers o~ IgE receptors on the cell surface [22) , and different secretory fun ctional responses to secretagogues (6, 8, 12, 16] . It has been demonstrated that the same mast-cell precursor can differe ntiate into heterogeneous populations of mast cells in different local tissues [27, 28] . Kitamura et al speculated that even in the same tissue the influence of the microenvironment might also' allow the dev; lopment of more than one type of mas t cell [29] . . In conc.lusion, methods are presented to extract and partially punfy functional CMC and PMC from BALB/c mice, which may be studied in vitro . Furthermore, functional heterogeneity was demonstrated between these rwo types of mast cells. Because of the ease in obtaining cells from these animaJs, CMC ofBALB/c mice should serve as an ideal source for the study of cutaneous infl ammation.
